Clinical Trial Update: Ancillary T Cell Based Studies in SPIROMICS

View source ↗

Summary

An update on ancillary T cell–based studies within the SPIROMICS COPD trial, noting that these ancillary investigations have completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Snippet

Sponsor: University of California, San Francisco | Conditions: Smoke Induced Lung Disease | Status: COMPLETED